Congenital Sucrase Deficiency
📧 Sign up to get email alerts when something new happens for Congenital Sucrase Deficiency.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-08-02FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) by QOL Medical, LLC.
-
FDA approval · 2015-09-21FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) submitted by QOL Medical, LLC.
-
FDA approval · 2015-02-16FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
FDA approved a supplemental application for SUCRAID (sacrosidase) from QOL Medical, LLC.
-
FDA approval · 2014-11-07FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
FDA approved a supplemental application for SUCRAID (sacrosidase) submitted by QOL Medical, LLC.
-
FDA approval · 2006-11-03FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
The FDA approved a supplemental application for SUCRAID (sacrosidase) from QOL Medical, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.